Home › Essential Thrombocythemia › Ohio › Columbus
Essential Thrombocythemia clinical trials in Columbus, OH
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Ohio State University, Columbus
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RecruitingPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Baltimore, MD4 studies
- Nashville, TN4 studies
- Salt Lake City, UT4 studies
- Boston, MA4 studies
- Miami, FL4 studies
- Mountain View, CA4 studies
- Irvine, CA3 studies
- St. Louis, MO3 studies
- Los Angeles, CA3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.